Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes. (2022)
Attributed to:
The effect of AIP mutations on the apoptotic RET pathway in pituitary adenomas
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/jendso/bvab190
PubMed Identifier: 35059545
Publication URI: http://europepmc.org/abstract/MED/35059545
Type: Journal Article/Review
Volume: 6
Parent Publication: Journal of the Endocrine Society
Issue: 2
ISSN: 2472-1972